Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer

被引:87
作者
Facchiano, E. [1 ]
Scaringi, S. [1 ]
Kianmanesh, R. [1 ]
Sabate, J. M. [2 ]
Castel, B. [1 ]
Flamant, Y. [1 ]
Coffin, B. [2 ]
Msika, S. [1 ]
机构
[1] Univ Paris 07, AP HP, Louis Mourier Hosp, Dept Surg, F-92701 Colombes, France
[2] Univ Paris 07, AP HP, Louis Mourier Hosp, Dept Hepatogastroenterol, F-92701 Colombes, France
来源
EJSO | 2008年 / 34卷 / 02期
关键词
laparoscopy; hyperthermic intraperitoneal chemotherapy; peritoneal carcinomatosis; ascites; gastric cancer;
D O I
10.1016/j.ejso.2007.05.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: To review our experience of laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of malignant ascites from advanced gastric cancer in order to discuss benefits, problems and possible indications. Methods: From June 2000 to May 2003 laparoscopic approach was used to perform HIPEC on five patients affected by malignant ascites secondary to unresectable peritoneal carcinomatosis of gastric origin, in order to associate the benefits of a definitive palliation of ascites with a minimal invasiveness. All patients had ascites related symptoms requiring iterative paracenteses. Intraperitoneal perfusion of mitomycin-C and cisplatin was delivered for 60-90 min with an inflow temperature of 45 degrees C. Results: Complete clinical regression of ascites and related symptoms was achieved in all the five patients treated. Intraoperative course was uneventful in all cases. Mean operative time was 181 min. No postoperative deaths, related to the procedure, occurred. Only a case of delayed gastric empting was recorded as a minor postoperative complication. Conclusions: Laparoscopic HIPEC appears to be a safe and effective procedure to treat debilitating malignant ascites from unresectable peritoneal carcinomatosis. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:154 / 158
页数:5
相关论文
共 20 条
[1]   Laparoscopic continuous hyperthermic peritoneal perfusion [J].
Chang, E ;
Alexander, HR ;
Libutti, SK ;
Hurst, R ;
Zhai, SP ;
Figg, WD ;
Bartlett, DL .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2001, 193 (02) :225-229
[2]  
CHU DZJ, 1989, CANCER, V63, P364, DOI 10.1002/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO
[3]  
2-V
[4]  
Elias D, 2001, CANCER, V92, P71, DOI 10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO
[5]  
2-9
[6]   Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites [J].
Garofalo, A. ;
Valle, M. ;
Garcia, J. ;
Sugarbaker, P. H. .
EJSO, 2006, 32 (06) :682-685
[7]  
Gilly FN, 1999, ANTICANCER RES, V19, P2317
[8]   Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia [J].
Glehen, O ;
Mohamed, F ;
Gilly, FN .
LANCET ONCOLOGY, 2004, 5 (04) :219-228
[9]   Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinornatosis:: Morbidity and mortality analysis of 216 consecutive procedures [J].
Glehen, O ;
Osinsky, D ;
Cotte, E ;
Kwiatkowski, F ;
Freyer, G ;
Isaac, S ;
Trillet-Lenoir, V ;
Sayag-Beaujard, AC ;
François, Y ;
Vignal, J ;
Gilly, FN .
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (08) :863-869
[10]   Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis [J].
Gretschel, S. ;
Siegel, R. ;
Estevez-Schwarz, L. ;
Huenerbein, M. ;
Schneider, U. ;
Schlag, P. M. .
BRITISH JOURNAL OF SURGERY, 2006, 93 (12) :1530-1535